# CustomSurg

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/customsurg

- Industry: Medical Devices & Equipment
- Headquarters: Zurich, Switzerland
- Website: www.customsurg.com/
- Latest round: Seed (Mar 18, 2024)
- Investors on record: 3

## About

Based in Zurich, Switzerland, CustomSurg AG is a medical device venture focused on the field of bone fracture treatment. The company was founded by Thomas Zumbrunn (co-CEO), Arvind von Keudell (CMO), and Valentin Splett (co-CEO). In March 2024, CustomSurg raised seed funding led by investor CHMBR Partners LLC, with participation from other investors Kickfund and High-Tech Gründerfonds. 

The company’s product prioritizes personalized treatment for bone fractures, providing customized solutions for each patient's unique condition. The company specializes in addressing intricate bone fractures, presenting a significant opportunity for surgeons, implant producers, and healthcare systems. 

The company will use the March 2024, funding to accelerate the FDA regulatory application process, launch the first-in-human study and establish its presence in the US market.

## Funding rounds

- Seed, Mar 18, 2024 — High-Tech Gruenderfonds, CHMBR Partners LLC, Kickfund

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- CHMBR Partners LLC — Seed
- Kickfund (https://capitalatlas.ai/funds/kickfund) — Seed